Test codes: 11361, 11362, 11363; 16504, 16505, 16506; 70048, 70049, 70051

References

  1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
  2. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol. 2003;41(1):304-309.
  3. Van der Pool B, Chernesky M, Gaydos G, et al. Multicenter comparison of nucleic acid amplification tests for the diagnosis of rectal and oropharyngeal chlamydia trachomatis and neisseria gonorrhoeae infections. J Clin Microbiol. 2022;60(1):e0136321.
  4. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Consultation Meeting summary report. January 13-15, 2009. Atlanta, GA. http://www.aphl.org/aphlprograms/infectious/std/Documents/ID_2009Jan_CTGCLab-Guidelines-Meeting-Report.pdf. Accessed June 20, 2014.

 

This FAQ is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on the physician’s education, clinical expertise, and assessment of the patient.

 

Document FAQS.154 Version: 2

Version 2: effective 04/19/2024 to present

Version 1: effective 02/29/2016 to 04/19/2024
Version 0: effective 12/05/2014 to 02/28/2016